TopMedTalk

Where are we with the journey from Enhanced Recovery (ER) to Perioperative Medicine? Is it fair to characterise the latter as "Enhanced Recovery v2.0"? Mike Grocott explains how the Royal College of Anaesthetists (RCoA) have set up a plan for "perioperative care" going forward. Does this terminology, "perioperative care" help? Also - news about the "international board of perioperative medicine", how are the challenges of the global ambition for this movement being met?

Monty Mythen and Desiree Chappell with Mike Grocott.

Where are we with the journey from Enhanced Recovery (ER) to Perioperative Medicine? Is it fair to characterise the latter as "Enhanced Recovery v2.0"? Mike Grocott explains how the Royal College of Anaesthetists (RCoA) have set up a plan for "perioperative care" going forward. Does this terminology, "perioperative care" help? Also - news about the "international board of perioperative medicine", how are the challenges of the global ambition for this movement being met?

Monty Mythen and Desiree Chappell with Mike Grocott.

How important is 'expectation management' in pediatrics? What could the usefulness of cannabis be as a way of reducing reliance on opioids? Is research in this area growing?

Desiree Chappell and Mike Grocott interview their guest Myron Yaster, Children's Hospital Colorado.

How important is 'expectation management' in pediatrics? What could the usefulness of cannabis be as a way of reducing reliance on opioids? Is research in this area growing?

Desiree Chappell and Mike Grocott interview their guest Myron Yaster, Children's Hospital Colorado.

Recognising and treating pain in children has gone through significant change over the years, this is a trend that looks set to continue. With a focus upon Enhanced Recovery (ER), what are the pathways for the pediatric patient? Should we be looking more at opioid reduction rather than opioid avoidance? How large a part of the problem is the dispensation of opioids and the "bystander risk" - where they go unused but are kept in a drugs cabinet at home, posing a risk to curious teenagers? How much of an issue are opioids and their negative consequences in pediatrics? How should one dispose of opioids?

Desiree Chappell and Mike Grocott interview their guest Myron Yaster, Children's Hospital Colorado.

Recognising and treating pain in children has gone through significant change over the years, this is a trend that looks set to continue. With a focus upon Enhanced Recovery (ER), what are the pathways for the pediatric patient? Should we be looking more at opioid reduction rather than opioid avoidance? How large a part of the problem is the dispensation of opioids and the "bystander risk" - where they go unused but are kept in a drugs cabinet at home, posing a risk to curious teenagers? How much of an issue are opioids and their negative consequences in pediatrics? How should one dispose of opioids?

Desiree Chappell and Mike Grocott interview their guest Myron Yaster, Children's Hospital Colorado.

The conversation from part 1 continues with questions such as; what specific anaesthesia protocols do you use? Is there room in this context to consider a drug diversion programme? Is phenylephrine a good choice for these procedures?

There is also a special mention for The Society for Obstetric Anesthesia and Perinatology (SOAP) - you can find their website here: https://soap.org/

Desiree Chappell and Monty Mythen interview their guest Laurent Bollag, M.D., is UW Medicine's chief of Obstetric Anesthesia and a UW associate professor or Anesthesiology and Pain Medicine.

The conversation from part 1 continues with questions such as; what specific anaesthesia protocols do you use? Is there room in this context to consider a drug diversion programme? Is phenylephrine a good choice for these procedures?

There is also a special mention for The Society for Obstetric Anesthesia and Perinatology (SOAP) - you can find their website here: https://soap.org/

Desiree Chappell and Monty Mythen interview their guest Laurent Bollag, M.D., is UW Medicine's chief of Obstetric Anesthesia and a UW associate professor or Anesthesiology and Pain Medicine.

The conversation begins with some thoughts on Enhanced Recovery (ER) for the obstetric patient. Further discussion covers the "transatlantic" differences between the US, UK and the wider EU. Where does pain management fit into the ceasarian section (c-section) debate? What are the advantages of a drug diversion programme in that respect? The issue of fluid management in the operating room is discussed. What is Evidence Based Obstetric Anaesthesia? Desiree Chappell and Monty Mythen interview their guest Laurent Bollag, M.D., is UW Medicine's chief of Obstetric Anesthesia and a UW associate professor or Anesthesiology and Pain Medicine.

The conversation begins with some thoughts on Enhanced Recovery (ER) for the obstetric patient. Further discussion covers the "transatlantic" differences between the US, UK and the wider EU. Where does pain management fit into the ceasarian section (c-section) debate? What are the advantages of a drug diversion programme in that respect? The issue of fluid management in the operating room is discussed. What is Evidence Based Obstetric Anaesthesia?
  Desiree Chappell and Monty Mythen interview their guest Laurent Bollag, M.D., is UW Medicine's chief of Obstetric Anesthesia and a UW associate professor or Anesthesiology and Pain Medicine.